First-of-its-Kind Flight Trials Integrate Uncrewed Aircraft Into Controlled Airspace
A partnership of aviation leaders demonstrates that uncrewed aircraft can be safely integrated into controlled…
3 years ago
Wire Stories
University of Cincinnati and University of International Business and Economics Attain Prestigious Global Centers of Insurance Excellence Designation for 2023
NEW YORK--(BUSINESS WIRE)--The International Insurance Society (IIS) has named the University of Cincinnati Carl H.…
3 years ago
India Electric Three-Wheelers (E3Ws) Battery Swapping Analysis Report 2023 Featuring Battery Smart, Chargeup, Honda (HEID), RACE Energy, Sun Mobility, and VoltUp – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Strategic Analysis of Battery Swapping for Electric Three-Wheelers (E3Ws) in India" report has…
3 years ago
Phocas Announces AI Functionality to Make Data Analysis Easier for Business People
COSTA MESA, Calif.--(BUSINESS WIRE)--Phocas Software, a cloud SaaS company specializing in business planning and analytics,…
3 years ago
Jazwares Acquires Australian Toy Distributor Big Balloon
SUNRISE, Fla.--(BUSINESS WIRE)--Jazwares, a leading global toy company, today announced it has further expanded its…
3 years ago
Visa and Oxfam America to Explore Expanding Anticipatory Action Program to Bring Pre-Disaster Financial Support to the Philippines, Kenya, Colombia, and Puerto Rico
At COP28, the organizations announced intent to scale the B-READY Project to provide preventative humanitarian…
3 years ago
SIPAL S.P.A. and Odysight.ai Join Forces to Create Advanced Visual Based Health Monitoring System
Advanced Visual Based Health Monitoring System Odysight.ai Inc. Carson City, Nevada, Dec. 04, 2023 (GLOBE…
3 years ago
SIPAL S.P.A. and Odysight.ai Join Forces to Create Advanced Visual Based Health Monitoring System
Advanced Visual Based Health Monitoring System Odysight.ai Inc. Carson City, Nevada, Dec. 04, 2023 (GLOBE…
3 years ago
Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib
Pimicotinib (ABSK021) is currently in a global Phase III study in tenosynovial giant cell tumor…
3 years ago
Merck KGaA, Darmstadt, Germany Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib
Pimicotinib (ABSK021) is currently in a global Phase III study in tenosynovial giant cell tumor…
3 years ago